CAS 1384860-29-0

Conteltinib

CAS: 1384860-29-0

Conteltinib

Pureza: ≥98%

Peso molecular: 635.82g/mol

Ref: 54-BUP08460

Conteltinib

CAS: 1384860-29-0

Conteltinib is an orally-administered, potent and selective inhibitor of fibroblast activation protein (FAP) that has been shown to inhibit the proliferation and migration of myofibroblasts in vitro. Conteltinib also inhibits the growth of various cancers in mice, including colorectal cancer, lung cancer, pancreatic cancer and prostate cancer. The mechanism by which conteltinib inhibits FAP is not known, but it may be due to multivalent binding or inhibition of FAP proteolytic activity. Conteltinib is being investigated as a potential treatment for fibrotic diseases such as idiopathic pulmonary fibrosis.

Fórmula: C₃₂H₄₅N₉O₃S

Pureza: Min. 95%

Peso molecular: 635.8 g/mol

Ref: 3D-JFC86029

Conteltinib

CAS: 1384860-29-0

Conteltinib (CT-707) is an enzyme inhibitor with antitumor activity targeting FAK, ALK and Pyk2. It can be used to study lymphoma.

Fórmula: C₃₂H₄₅N₉O₃S

Pureza: 98.12% - 99.54%

Cor e Forma: Solid

Peso molecular: 635.82

Ref: TM-T14997